Clin2
NCT04892251Possibly a fitRecruiting

Ketamine-assisted therapy for opioid use disorder

Opioid-use Disorder

Part of Mental health clinical trials.

This trial tests whether ketamine-assisted therapy can help people with opioid use disorder, alongside standard treatment with buprenorphine. It also looks at whether you can safely take part in group mindfulness-style sessions during the study.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a diagnosis of opioid use disorder
  • You are currently receiving opioid use disorder treatment with buprenorphine
  • You have not previously taken part in a mindfulness-based program
  • You are not pregnant (and not breastfeeding)
  • You have no serious medical or mental conditions that would stop you from joining mindfulness-style group sessions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07369089Not yet recruiting· Phase 2
Ketamine therapy for opioid addiction

This study tests if combining ketamine with a mindfulness program can help people who are still struggling with opioid use while on buprenorphine. If you are already taking buprenorphine but still using opioids, this treatment may offer additional support to help you stop.

La Jolla, California
NCT06943859Recruiting· Phase 2
Ketamine for opioid use disorder during methadone treatment

This study tests if a medicine called ketamine, given during methadone treatment, can help people reduce their use of opioids. It is for people who recently started methadone and have been using opioids heavily.

Baltimore, Maryland
NCT06642181Recruiting· Phase 1
Guanfacine and meditation with buprenorphine for opioid use disorder

This study tests if adding a medication called guanfacine and mindfulness meditation to standard buprenorphine treatment helps people with opioid use disorder. It looks at whether this combination can improve treatment outcomes and reduce opioid use.

Newark, New Jersey
NCT06585709Recruiting
Brain stimulation for opioid use disorder treatment

This trial tests if brain stimulation can help people starting buprenorphine for opioid use disorder. It aims to improve treatment outcomes and support recovery.

Durham, North Carolina
NCT07009158Not yet recruiting· Phase 1/Phase 2
Ketamine plus therapy for pain and PTSD

This trial tests if ketamine combined with talk therapy helps people with both chronic pain and PTSD. Participants receive ketamine through an IV in group therapy sessions over several weeks, with the goal of reducing pain and PTSD symptoms.

NCT07247006Not yet recruiting· Phase 2
Ketamine with therapy for hard-to-treat depression

This trial is testing whether a combination of ketamine and talk therapy can help people with depression that hasn't responded to other treatments. You will receive ketamine in a safe, supervised setting while working with a therapist.

Rochester, New York

Hear when a new Opioid Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.